T1DM Flashcards
ambiguity between T1 and T11
there is autoimmune diabetes leading to insulin deficiency called LADA- similar to T1: monogenic diabetes can also present similarly children may get T11DM ketoacidosis is a feature of late T2DM diabetes may be due to endocrine damage eg cushings/phaeochromocytoma/ALCHOL
pathogenesis of T1DM
autoantibodies against B cells destroy them, causing C peptide BELOW DETECTION- - may be because effector T cells exceed regulator T cells
why immune change in T1DM important
can lead to increased risk of autoimmune disease eg B12 deficiency/addisons, as well as in relatives (family history) antibodies can also be measured for treatment eg islet cell antibodies/insulin antibodies- more prevalent in T1 diabetics
genetic susceptibility
HLA markers on Chr6- DR3/4 alleles increase risk significantly
environmental factors
increased prevalence in winter, possibly due to virus- also more prevalent in different parts of world
symptoms of diabetes
osmotic symptoms (poly/noct/polydipsia) blurry vision thrush (candida infection= rashes) weight loss fatigue
signs of diabetes
dehydration hyperventilation (kussmahls) glycos/ketonuria cachexia (weakness of body)
important organs involved in T1DM
liver, muscle and adipocytes- glucose produced by liver goes into blood, lack of insulin prevents glucose taken into muscle: muscle releases a.a’s, and adipocyte releases glycerol, both of which produce even more glucose in liver, exacerbating hyperglycaemia fatty acids from LIPOLYSIS (NOT glycerol) become ketone bodies (acetoacetate+ hydroxybutyrate) (in liver
aims of treatment of T1DM
prevent early mortality, and long term micro/macrovascular complications (retin/nephro/neuropathy and vascular disease)
diet in T1DM
reduce fat calories, less refined/more complex carbs + more soluble fibre
insulin treatment DIAGRAM
SHORT ACTING insulin given with meals, as well as BACKGROUND insulin (lasts longer)- depending on when meals eaten, there is FLEXIBILITY in insulin treatment insulin pump also given as injecting insulin time consuming- leads to continuous insulin prodcution
islet cell transplants
extract from an individual and given to patient via portal vein- problem is patients are immunosurpressed their whole life
how to monitor treatment+ problems where appropriate
capillary glucose levels (not as accurate as venous glucose levels) CGM’s (continuous glucose monitoring)- alerts you when glucose goes out of target range: works as correlates with lower HBA1C’s HBA1C
explain HBA1C, target+ problem+ why so good
reflection of glucose over 3 months (should be below 42mmol, above 48 is diabetes) as haemoglobin carries glucose- those with anaemia shouldn’t use this, as RBC’s die quickly, so not reflective HBA1C as shows long term glycaemic control- closely linked with microvascular complications
acute effects of T1DM
hyperglycaemia- glucose used by muscle/fat, and liver producing glucose as well metabolic acidosis/ketoacidosis- pH, HCO3- and CO2 low (due to hyperventilation)